Skip to content

RXST - RxSight, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchR

Rxsight Inc

RXST · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

R

RXSTRxsight Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $13.22
52-wk low: $4.48
Prev close: $9.09
Mkt cap: $264.9M
Fwd P/E: 116.3x
Beta: 1.13

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$78.2M

MI
Millennium
Israel Englander · Q2 2026 13F
$14.6M
position
DS
D.E. Shaw
Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in 21.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -36.8%
Forward P/E: 116.28
Market cap: $265M

Valuation

P/S2.01
P/B1.01

Quality

Operating margin-40.8%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: RXST
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Market cap: $264.95M
Beta: 1.13

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

2.0x

P/B

1.0x

Profit margin

-36.8%

Op margin

-40.8%

ROE

-17.3%

$9.6M

position

AQ

AQR

Q2 2026 13F

$7.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for RXST

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.29+21.6%

-$0.37 expected

Next report

What the street expects next

ROE

-17.3%

ROA-10.4%

Growth

Beta1.13